SCHEMBL9704446

SCHEMBL9704446

COc1cc(S(C)(=O)=O)ccc1-c1nc2cc3c(cc2[nH]1)C(C)(C)C(=O)NC3=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.42
CCNA2 P20248 1/20 0.42
CCND1 P24385 1/20 0.42
CDK2 P24941 1/20 0.42
CCND3 P30281 1/20 0.42
PDE3B Q13370 2/20 0.41
PDE3A Q14432 2/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
AURKA O14965 1/20 0.40
AURKB Q96GD4 1/20 0.40
NPBWR1 P48145 1/20 0.39
SCD O00767 5/20 0.38
AMY1A P0DUB6 2/20 0.38
CBFB Q13951 1/20 0.37
FADS1 O60427 1/20 0.37
PDE5A O76074 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10373442 0.87 PDE3B (0.48) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9383861 0.85 CDK4 (0.41) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9703428 0.84 PDE3B (0.41) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9703335 0.79 CDK4 (0.47) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9703598 0.79 CDK4 (0.41) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10373891 0.78 PDE3B (0.47) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10376119 0.77 PDE3B (0.46) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10373740 0.77 PDE3B (0.46) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9702805 0.76 CDK4 (0.45) CDK4CCNA2CCND1CDK2CCND3
Hydrochloric Acid SCHEMBL10698205 0.76 AURKA (0.52) CDK4CCNA2CCND1CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed